It epigenetically promotes tumor cell proliferation in pancreatic neuroendocrine neoplasms by inhibiting the tumor suppressor p57Kip2 and the mTOR pathway [43]. The gene discussed is MTOR; the disease is pancreatic neuroendocrine neoplasm.